Molecular and biological characterization of a murine ligand for CD40 - Wikidata - awgldk - TriplyDB

Molecular and biological characterization of a murine ligand for CD40

Molecular and biological characterization of a murine ligand for CD40

http://www.wikidata.org/entity/Q28186605

about

BAFF, a novel ligand of the tumor necrosis factor family, stimulates B cell growth Involvement of CRAF1, a relative of TRAF, in CD40 signaling Human CD100, a novel leukocyte semaphorin that promotes B-cell aggregation and differentiation Cloning of a murine IL-11 receptor alpha-chain; requirement for gp130 for high affinity binding and signal transduction Human CD40-ligand: molecular cloning, cellular distribution and regulation of expression by factors controlling IgE production Molecular characterization of murine and human OX40/OX40 ligand systems: identification of a human OX40 ligand as the HTLV-1-regulated protein gp34 Regulation of aicda expression and AID activity: relevance to somatic hypermutation and class switch DNA recombination TRAF5, a novel tumor necrosis factor receptor-associated factor family protein, mediates CD40 signaling Follicular helper T cells: lineage and location Soluble and membrane-bound forms of signaling lymphocytic activation molecule (SLAM) induce proliferation and Ig synthesis by activated human B lymphocytes The CD40, CTLA-4, thyroglobulin, TSH receptor, and PTPN22 gene quintet and its contribution to thyroid autoimmunity: back to the future Knowledge-based model building of proteins: concepts and examples Two differently regulated nuclear factor kappaB activation pathways triggered by the cytoplasmic tail of CD40 The role of the T follicular helper cells in allergic disease A brief history of T cell help to B cells Cytokine production and dysregulation in HIV pathogenesis: lessons for development of therapeutics and vaccines Generation of Human B-Cell Lines Dependent on CD40-Ligation and Interleukin-4 A Short History of the B-Cell-Associated Surface Molecule CD40 CD40 immunotherapy for pancreatic cancer Crystallographic and Mutational Analysis of the CD40-CD154 Complex and Its Implications for Receptor Activation Pathophysiological roles for IL-18 in inflammatory arthritis CD27-CD70 interaction: unravelling its implication in normal and neoplastic B-cell growth Hyper immunoglobulin M syndrome due to CD40 deficiency: clinical, molecular, and immunological features CD154-CD40 interactions in the control of murine B cell hematopoiesis NF-kappaB is involved in the regulation of CD154 (CD40 ligand) expression in primary human T cells Multiple cytokines sharing the common receptor gamma chain can induce CD154/CD40 ligand expression by human CD4+ T lymphocytes via a cyclosporin A-resistant pathway Identification of TRAF6, a novel tumor necrosis factor receptor-associated factor protein that mediates signaling from an amino-terminal domain of the CD40 cytoplasmic region The structural basis of hyper IgM deficiency - CD40L mutations.Hyper IgM syndrome associated with defective CD40-mediated B cell activation Cyclosporin A inhibits CD40 ligand expression in T lymphocytes.CD40 ligand expression is defective in a subset of patients with common variable immunodeficiency.Defective expression of the CD40 ligand in X chromosome-linked immunoglobulin deficiency with normal or elevated IgM Three novel mutations reflect the variety of defects causing phenotypically diverse X-linked hyper-IgM syndrome.Quantal and graded stimulation of B lymphocytes as alternative strategies for regulating adaptive immune responses Characterization of a novel human surface molecule selectively expressed by mature thymocytes, activated T cells and subsets of T cell lymphomas.A Salmonella typhi OmpC fusion protein expressing the CD154 Trp140-Ser149 amino acid strand binds CD40 and activates a lymphoma B-cell line.T cell receptor VB repertoire diversity in patients with immune thrombocytopenia following splenectomy.New insights and therapeutics for immune-mediated thrombocytopenia.A phase 1 study of lucatumumab, a fully human anti-CD40 antagonist monoclonal antibody administered intravenously to patients with relapsed or refractory multiple myeloma.Mapping of the X linked form of hyper IgM syndrome (HIGM1)

P2860

Q22009942-862C7133-B919-44A6-8994-D062EB3256D4 Q24306746-99E2A572-1D56-4864-A36D-FF4497667965 Q24314914-82CFAFE4-FFCF-4D2D-8A89-F482AB6602CA Q24336395-DA918C39-52A9-40F5-B536-3924E6F93369 Q24337552-97964A62-A813-4A37-8D1B-A1B515BCA6BB Q24568305-AFB4EE70-3A04-42DD-9A28-58346AE9934A Q24633098-C1A43030-19D1-4A3E-95B4-FF364CFE5C71 Q24634187-B7C19BB3-44CE-442C-A1FE-0528BB0D398F Q24647274-B125B949-C51C-49BA-B476-BF33EAEE4DC4 Q24669982-5D5D55AF-AA84-4ABE-825F-9DE41FF4128F Q24673258-2C6FB631-B70D-45B2-BA0D-1232E2DC7B8B Q24676038-CC1FC1EE-47D8-43B8-BDBD-F81219721598 Q24676338-EF3F30EE-589C-4660-91C4-F720B907E758 Q26824290-6E0F6C4D-1EE1-469A-821E-5256980E977A Q26825185-7011CD3E-2E9C-474A-8A57-F2E97901ED20 Q26827712-9D683CCE-2C7E-4151-BAF0-C0ACFACA62A8 Q27005880-6753F4DF-612E-4562-B957-804EA9D00239 Q27007137-C01F0F73-07FE-4244-84EC-5B2982FDC305 Q27012550-BEB81ACE-8BF4-4676-AD3C-435AE0CB162D Q27666816-0723F1B3-B4C1-4F12-9A45-1F55E669B517 Q28187644-2A48A782-352A-43FC-A147-9FE01A20CADB Q28274504-300C9C1F-8285-4D17-BDD2-7968FD9428FA Q28303338-CE5BC24B-48FF-475D-9194-4CE95051BCE4 Q28305580-B02743F0-334C-4BCE-9F8E-6472151C3CB4 Q28347536-0ACA5C97-3B74-4DB1-859D-B03DE0EBFA00 Q28365233-81F5E613-82B4-4F5C-8E65-EA55F3219921 Q28511583-17150B61-7BA5-494C-A7CE-77E722B6AA46 Q30359929-64E70889-4D6C-4F91-9FEC-B0C35B6565E6 Q30449257-C92A2359-A22E-493D-A6DC-C2F2B77CB8C9 Q30449273-8BD3DD8E-0A29-41A7-8DAD-9B99564396CA Q30453877-418CB0FF-BFB8-4FA3-8D88-A8F3730486E4 Q30454072-C080D594-E454-41A8-B6D0-6FC035C47805 Q30540413-0E67C5CE-5C93-470A-B694-1D62CA5FE1FC Q30545732-82B1A61E-B6D1-449F-B062-7B3E7CBBAD9D Q31406838-36C9C6BF-77A4-4757-922D-6D4A797BA7A4 Q33193416-599BC159-83DE-44D4-BA5F-BA7EC9843467 Q33349600-F258C5C4-C19F-4045-B2DA-5F46987C075C Q33377901-E6E87C2E-FE3E-4E46-B79A-770CB013642C Q33402671-2611E9EE-4AEA-4CB5-94C9-9F1DCA8FFE27 Q33595078-B438D43D-9E76-461C-AEB4-A9EC82653F60

P2860

Molecular and biological characterization of a murine ligand for CD40

http://www.wikidata.org/entity/Q28186605

description

1992 nî lūn-bûn

@nan

1992 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

1992 թվականի մայիսին հրատարակված գիտական հոդված

@hy

1992年の論文

@ja

1992年論文

@yue

1992年論文

@zh-hant

1992年論文

@zh-hk

1992年論文

@zh-mo

1992年論文

@zh-tw

1992年论文

@wuu

name

Molecular and biological characterization of a murine ligand for CD40

@ast

Molecular and biological characterization of a murine ligand for CD40

@en

Molecular and biological characterization of a murine ligand for CD40

@nl

type

label

Molecular and biological characterization of a murine ligand for CD40

@ast

Molecular and biological characterization of a murine ligand for CD40

@en

Molecular and biological characterization of a murine ligand for CD40

@nl

prefLabel

Molecular and biological characterization of a murine ligand for CD40

@ast

Molecular and biological characterization of a murine ligand for CD40

@en

Molecular and biological characterization of a murine ligand for CD40

@nl

P1433

Q28186605-AAF2E780-9A3D-47E8-A920-30055F48E70D

P1476

Q28186605-A1060C03-5087-4C9C-8031-5A666725EE0E

P2093

Q28186605-4190DDA4-75E2-4C02-AF2A-F5C66C833E49

Q28186605-421E3625-E0A7-4381-90D5-62887F47C36C

Q28186605-458149ED-9FBF-452F-9F08-D8D8BEAF3356

Q28186605-5676E079-B22D-42B6-8254-7D52B7F79597

Q28186605-62949245-147E-4B7A-A0CE-77BA61BF5E8C

Q28186605-785A684A-6B49-4A6B-8036-E053ED049CA0

Q28186605-8E9DA390-ED32-4754-9225-41A2A0865DF5

Q28186605-9EAF0F7F-7E72-453D-9EDF-25D509C92ADE

Q28186605-A14611BE-3793-49AF-B09E-25F61A50F288

Q28186605-EBA78EAF-44E8-419A-ADA6-85BA0FD8F2FF

P2860

Q28186605-1821F3A4-48E6-4EB8-B27C-F0D775EDB438

Q28186605-36A911BB-CDB8-4D4C-B252-50F4DF583166

Q28186605-5CBF7BAA-AB8C-4D2F-949E-36CF915FAE21

Q28186605-6093229B-9395-460E-B0ED-67747F379198

Q28186605-77EDA547-5472-4428-9C29-A5BDC2AFA19C

Q28186605-937FDE47-1F42-4B07-A8DE-7BCFAA4643A2

Q28186605-AE1E72E5-8FB6-4133-8C3B-DFD574E35597

Q28186605-AE9DEEF0-D7FF-4A23-8E85-2E64AC4641F1

P2888

Q28186605-5B879054-E81B-4DA9-BA47-C2BC15D07DE3

P304

Q28186605-582153A8-5A07-457A-AD82-C0618D1446C9

P31

Q28186605-74919099-ADD1-4EF3-ABCA-7498C245CFA7

P3181

Q28186605-609B63C1-1B66-42B0-B6CE-763662445ABB

P356

Q28186605-034BF593-2200-4D5E-8F3B-89AD03F5F14D

P407

Q28186605-3159635B-8B5D-4140-8C22-9D24055990F8

P433

Q28186605-5C6B936F-27F8-4F0F-8C2B-718E9B80EE1C

P478

Q28186605-60A2C5D5-8839-4FCD-9977-421937E46C0C

P577

Q28186605-EB019680-2EAC-4FEE-BB87-D060A547A8FD

P6179

Q28186605-5F291C9A-01DC-4D8C-8FA6-FE9DC436BE24

P698

Q28186605-3722C3E9-321D-41FA-A8C5-A9E549996320

P3181

P356

P1433

P1476

Molecular and biological characterization of a murine ligand for CD40

@en

P2093

B M Macduff

http://www.w3.org/2001/XMLSchema#string

C R Maliszewski

http://www.w3.org/2001/XMLSchema#string

D M Anderson

http://www.w3.org/2001/XMLSchema#string

K N Clifford

http://www.w3.org/2001/XMLSchema#string

L Strockbine

http://www.w3.org/2001/XMLSchema#string

R J Armitage

http://www.w3.org/2001/XMLSchema#string

S D Gimpel

http://www.w3.org/2001/XMLSchema#string

T A Sato

http://www.w3.org/2001/XMLSchema#string

T Davis-Smith

http://www.w3.org/2001/XMLSchema#string

W C Fanslow

http://www.w3.org/2001/XMLSchema#string

P2860

Expression and structure of the human NGF receptor

Molecular cloning and expression of a receptor for human tumor necrosis factor

Gene transfer and molecular cloning of the rat nerve growth factor receptor

A novel form of TNF/cachectin is a cell surface cytotoxic transmembrane protein: ramifications for the complex physiology of TNF

CD40 and IgE: synergism between anti-CD40 monoclonal antibody and interleukin 4 in the induction of IgE synthesis by highly purified human B cells.

Molecular cloning and expression of the human 55 kd tumor necrosis factor receptor.

T2 open reading frame from the Shope fibroma virus encodes a soluble form of the TNF receptor.

Mechanism of antigen-driven selection in germinal centres

P2888

P304

80-2

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

183293

http://www.w3.org/2001/XMLSchema#string

P356

10.1038/357080A0

http://www.w3.org/2001/XMLSchema#string

P407

P433

6373

http://www.w3.org/2001/XMLSchema#string

P478

357

http://www.w3.org/2001/XMLSchema#string

P577

1992-05-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1018293308

http://www.w3.org/2001/XMLSchema#string

P698

1374165

http://www.w3.org/2001/XMLSchema#string